Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Duodenal Ulcer Perforation Following Tirzepatide Injections for Weight Loss Management: A Case Report
Cureus, 2026;18(9):e116411
Detection and Excretion Profile of Retatrutide in Human Plasma and Urine by LC-HRMS: Implications for Antidoping Analysis
Rapid communications in mass spectrometry : RCM;40(23):e70179
Impact of Semaglutide, Liraglutide and Tirzepatide on Cardiometabolic Outcomes: A Comparative Narrative Review
Endocrinology, diabetes & metabolism;9(5):e70338
When dose follows response: Interpreting lower-dose semaglutide effectiveness in clinical practice
Diabetic medicine : a journal of the British Diabetic Association, 2026;:e70479
Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial
JAMA cardiology, 2026
Obesity-Associated Osteoarthritis: Mechanical-Metabolic Pathogenesis, Obesity Memory and Dual-Target Therapy
Current obesity reports, 2026;15(1)
GLP-1 Receptor Agonists in Pulmonary Hypertension: Mechanistic Rationale, Preclinical Evidence, and Clinical Knowledge Gaps
Lung, 2026;204(1)
Adjunctive GLP-1 receptor agonists for cardiometabolic risk in antipsychotic-treated patients: A GRADE-assessed meta-analysis of randomized trials
Journal of psychopharmacology (Oxford, England), 2026;:2698811261478625
Sustained weight loss exceeding 100 kg with sequential incretin-based therapy in Prader-Willi syndrome
JCEM case reports, 2026;4(10):luag260
Postmenopausal bleeding associated with semaglutide: a diagnostic challenge
JCEM case reports, 2026;4(10):luag261
Glucagon-like peptide-1 receptor agonists as adjunctive therapy in refractory hypertriglyceridemia following recurrent pancreatitis
JCEM case reports, 2026;4(10):luag274
How to apply artificial intelligence (AI) to facilitate and enhance MASH trials
Hepatology international, 2026
From Gila Monster Venom to Dermatology: The History of GLP-1 Receptor Agonists
Clinics in dermatology, 2026
[GLP-1 Receptor Agonists in Urology and Andrology: Indications, Opportunities and Clinically Relevant Adverse Effects]
Zentralblatt fur Chirurgie, 2026
Response to Letter to the Editor regarding “Long-Term Mechanical Complications After Lumbar Fusion in Patients Receiving Tirzepatide vs Other GLP-1 Receptor Agonists”
Spine, 2026
Salcaprozate Sodium as a Permeation Enhancer-Mechanism, Applications and Unresolved Questions
Pharmaceutics, 2026;18(9)
Visceral Adiposity and Renal Health: From Pathophysiological Mechanisms to Novel Therapeutic Strategies
Journal of clinical medicine, 2026;15(18)
Cardiovascular protection beyond glucose lowering: GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonism in contemporary cardiology
Frontiers in cardiovascular medicine, 2026;13:1926629
Weighing the Risks and Benefits of Microdosing Tirzepatide Vials
Diabetes, obesity, and cardiometabolic CARE, 2026;1(5):e7-e9
Assessing the Growing Impact of Oral GLP-1 Agonists on National Obesity Policies of the United Kingdom
Cureus, 2026;18(9):e116274